IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human KeratinocytesKatia Boniface, Franck Morel|The Journal of Immunology|2005Cited by 841
Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligoM. Larsabal, Julien Sénéschal, Alain Taı̈eb et al.|Journal of the American Academy of Dermatology|2017Cited by 157
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligoNesrine Boukhedouni, Katia Boniface|JCI Insight|2020Cited by 67
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional studyL. Dousset, Julien Sénéschal, A. Pacaud et al.|JAAD International|2021Cited by 27
Vitiligo-like lesions in patients receiving anti–programmed cell death-1 therapies are distinct from spontaneously occurring active vitiligoKatia Boniface, Julien Sénéschal, Alain Taı̈eb et al.|Journal of the American Academy of Dermatology|2017Cited by 16